Investing Profile
Alan O'Connell
Your Intro Paths to Alan O'Connell
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Alan is a member of
Hotmail Network
4901 CONNECTIONS
Hotmail Network
4901 CONNECTIONS
Hotmail Network
4901 CONNECTIONS
Hotmail Network
4901 CONNECTIONS
University of London Network
20 CONNECTIONS
Find Alan O'Connell on
cbCurrent Investing Position
Seroba Life Sciences Partner
Investment Range
$5.0M - $7.0M
Sweet Spot
$6.0M
Investments On Record
7
Alan O'Connell is on these Sector & Stage Rankings
Alan O'Connell's Investments On Record (5)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Artica Therapeutics | SeedNov 2023$13M | $13M |
Shorla Pharma | Series BOct 2023$35M Series AJun 2020$8M | $43M |
Fusion Pharmaceuticals | Series BApr 2019$110M Series ASep 2017$21M | $130M |
Prexton Therapeutics | Series BFeb 2017$31M | $41M |
Heart Metabolics | Series AApr 2014$20M | $20M |
Alan O'Connell's Experience
Drug Information Officer HotmailPresent
Postdoctoral Research Fellow (Alzheimer’s disease / cognition) HotmailPresent
Product Development & Project Leader Elan PharmaceuticalsPresent
Product Development Manager (CNS drug development) HotmailPresent
Executive HotmailPresent
Joint-Venture Restructuring Team Elan PharmaceuticalsPresent
Scientific Advisory Board Member Alzheimer's Drug Discovery FoundationPresent
Partner Seroba.Present
Alan O'Connell's Education
University of London MSc Toxicology & Pathology
National University of Ireland, Galway PhD Neuropharmacology
University of Galway PhD Neuropharmacology
Investors who invest with Alan O'Connell
Founders who looked at Alan O'Connell's profile also looked at these Scouts & Angels